<![CDATA[This quantitative study examines how digital health interventions (DHIs), such as web-based platforms, telemonitoring, and mobile apps, affect patients with Type 2 diabetes mellitus (T2DM) in terms of self-efficacy, medication adherence, and glycemic control. 150 adults between the ages of 30 and 65 who had been using DHIs for at least three months were gathered from Makassar, Indonesia, outpatient clinics. A standardized questionnaire on digital usage, the Morisky Medication Adherence Scale (MMAS-8), the Diabetes Management Self-Efficacy Scale (DMSES), and clinical records of HbA1c were used to collect data. Multiple regression, t-tests, and Pearson correlation were among the statistical analyses carried out. The findings showed that self-efficacy, adherence, and engagement with digital tools were significantly positively correlated, and that regular users had reduced HbA1c levels. According to regression analysis, self-efficacy, adherence, and DHI use together accounted for 49% of the variance in glycemic control. When compared to infrequent users, regular users saw improvements in HbA1c that were clinically significant. All things considered, DHIs successfully improve clinical and behavioral outcomes in the management of diabetes. In order to improve long-term clinical results, empower self-management, and enhance patient-centered treatment, the study highlights the integration of digital tools into healthcare systems.]]>
Copyrights © 2025
